Cargando…
Evaluation of therapeutic strategies targeting BCAA catabolism using a systems pharmacology model
Background: Abnormal branched-chained amino acids (BCAA) accumulation in cardiomyocytes is associated with cardiac remodeling in heart failure. Administration of branched-chain α-keto acid dehydrogenase (BCKD) kinase inhibitor BT2 has been shown to reduce cardiac BCAA levels and demonstrated positiv...
Autores principales: | Voronova, Veronika, Sokolov, Victor, Morias, Yannick, Boezelman, Malin Jonsson, Wågberg, Maria, Henricsson, Marcus, Hansson, Karl, Goltsov, Alexey, Peskov, Kirill, Sundqvist, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9744226/ https://www.ncbi.nlm.nih.gov/pubmed/36518669 http://dx.doi.org/10.3389/fphar.2022.993422 |
Ejemplares similares
-
Targeting BCAA Catabolism to Treat Obesity-Associated Insulin Resistance
por: Zhou, Meiyi, et al.
Publicado: (2019) -
BCAA Catabolic Defect Alters Glucose Metabolism in Lean Mice
por: Wang, Ji, et al.
Publicado: (2019) -
A randomized placebo-controlled clinical trial for pharmacological activation of BCAA catabolism in patients with type 2 diabetes
por: Vanweert, Froukje, et al.
Publicado: (2022) -
Dataset reporting BCKDK interference in a BCAA-catabolism restricted environment
por: Bravo-Alonso, I., et al.
Publicado: (2016) -
BCKDK of BCAA Catabolism Cross-talking With the MAPK Pathway Promotes Tumorigenesis of Colorectal Cancer
por: Xue, Peipei, et al.
Publicado: (2017)